Hypothesis: Hyperbaric oxygen (HBO) therapy increases vascular endothelial
growth factor (VEGF) levels in wounds.
Design: Wounds were monitored fur oxygen delivery during HBO treatment, and
wound fluids were analyzed fur VEGF and lactate oil days 2, 5, and 10 foll
owing wounding.
Setting: Experimental animal model.
Interventions: Rats were randomized to HBO therapy and control groups. The
HBO therapy was administered for 90 minutes, twice daily with 100% oxygen a
t 2.1 atmospheres absolute. Treatment was administered for 7 days following
wounding.
Main Outcome Measures: Vascular endothelial growth factor, POL, and lactate
levels in wound fluid were measured on days 2, 5, and 10.
Results: Wound oxygen rises with HBO from nearly 0 mm Hg to as high as 600
mm Hg. The peak level occurs at the end of the 90-minute treatment, and hyp
eroxia of lessening degree persists for approximately 1 hour. The VEGF leve
ls significantly increase with HBO by approximately 40% 5 days following wo
unding and decrease to control levels 3 days after exposures are stopped. W
ound lactate levels remain unchanged with HBO treatment (range, 2.0-10.5 mm
ol/L).
Conclusions: Increased VEGF production seems to explain in part the angioge
nic action of HBO. This supports other data that hypoxia is not necessarily
a requirement for wound VEGF production.